Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

This study has been completed.

Sponsor:

Collaborator:

National Institute of Mental Health (NIMH)

Information provided by:

University of California, San Francisco

ClinicalTrials.gov Identifier:

NCT00071656

First received: October 29, 2003

Last updated: August 6, 2013

Last verified: August 2013

History of Changes

Purpose

The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability.

Condition	Intervention
Attention Deficit Disorder With Hyperactivity	Behavioral: Psychosocial (behavioral) Intervention


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Primary Purpose: Treatment
Official Title:	Psychosocial Treatment for ADHD Inattentive Type I

Resource links provided by NLM:

MedlinePlus related topics: Attention Deficit Hyperactivity Disorder

U.S. FDA Resources

Further study details as provided by University of California, San Francisco:


Estimated Enrollment:	60
Study Start Date:	September 2002
Study Completion Date:	June 2007

Detailed Description:

ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed.

Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.

Eligibility


Ages Eligible for Study:	7 Years to 11 Years (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

ADHD, Predominantly Inattentive Type
Public or private school attendance
English speaking

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00071656

Locations


United States, California
HALP Clinic, Children's Center at Langley Porter, UCSF
San Francisco, California, United States, 94143

Sponsors and Collaborators

University of California, San Francisco

National Institute of Mental Health (NIMH)

More Information


ClinicalTrials.gov Identifier:	NCT00071656 History of Changes
Other Study ID Numbers:	R21MH065927 ( US NIH Grant/Contract Award Number ) DSIR CT-S
Study First Received:	October 29, 2003
Last Updated:	August 6, 2013

Additional relevant MeSH terms:


Attention Deficit Disorder with Hyperactivity Hyperkinesis Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders	Dyskinesias Neurologic Manifestations Nervous System Diseases Signs and Symptoms

ClinicalTrials.gov processed this record on June 26, 2017

To Top